Monensin inhibits proliferation, migration, and promotes apoptosis of breast cancer cells via downregulating UBA2-Reference-Cited by-同舟云学术

Monensin inhibits proliferation, migration, and promotes apoptosis of breast cancer cells via downregulating UBA2

Published:2020-05-27 Issue:6 Volume:81 Page:745-753
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev Res

Author:

Gu Jiangtao¹²,Huang Lan³,Zhang Yunxia⁴

Affiliation:

1. Pharmaceutical DepartmentTianjin Baodi Hospital Tianjin China

2. Pharmaceutical DepartmentBaodi Clinical College of Tianjin Medical University Tianjin China

3. Clinical LaboratoryClinical Laboratory of Wuhan Ping'an Haoyi Clinical Lab Co., Ltd Wuhan Hubei Province China

4. Department of Thyroid and Breast Surgery, The Central Hospital of WuhanTongji Medical College, Huazhong University of Science and Technology Wuhan Hubei Province China

Publisher

Wiley

Subject

Drug Discovery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ddr.21683

Reference22 articles.

1. Breast cancer in young women: an overview

2. Radiation therapy and early breast cancer: current controversies

3. Knockdown of Uba2 inhibits colorectal cancer cell invasion and migration through downregulation of the Wnt/β‐catenin signaling pathway

4. Monensin Inhibits Epidermal Growth Factor Receptor Trafficking and Activation: Synergistic Cytotoxicity in Combination with EGFR Inhibitors

5. Antibiotic monensin synergizes with EGFR inhibitors and oxaliplatin to suppress the proliferation of human ovarian cancer cells

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the molecular mechanisms of Fuzheng Yiliu Shenji prescription in SH-SY5Y neuroblastoma cells;Frontiers in Oncology;2024-09-10

2. Golgi apparatus targeted therapy in cancer: Are we there yet?;Life Sciences;2024-09

3. Combination of monensin and erlotinib synergistically inhibited the growth and cancer stem cell properties of triple-negative breast cancer by simultaneously inhibiting EGFR and PI3K signaling pathways;Breast Cancer Research and Treatment;2024-07-03

4. Maduramicin-guided nanotherapy: A polymeric micelles for targeted drug delivery in canine mammary tumors;Biomedicine & Pharmacotherapy;2024-01

5. Inhibition of Wnt/β-catenin signaling by monensin in cervical cancer;The Korean Journal of Physiology & Pharmacology;2024-01-01